Authors

Heather G Mack

Email: hmack@eyesurgery.com.au

PhD, FRANZCO, Clinical Associate Professor of Ophthalmology, Department of Surgery (Ophthalmology), University of Melbourne, Vic


Hydroxychloroquine use during the COVID-19 pandemic 2020

At present, there are no studies demonstrating the clinical efficacy of hydroxychloroquine for the prophylaxis or treatment of COVID-19 infection.


Eyes

Developments in ophthalmic diagnosis and treatment have led to marked improvements in visual outcomes for patients in general practice.


Keeping an eye on COVID-19: Ophthalmic care and triage for general practitioners

The ability of general practitioners to triage ophthalmic conditions appropriately is critical in our fight against COVID-19.


Management of conjunctivitis and other causes of red eye during the COVID-19 pandemic

Caution needs to be observed during the COVID-19 pandemic if a patient’s symptoms align with a viral conjunctivitis.


Management of conjunctivitis during the COVID-19 pandemic 2020

Conjunctivitis may be a feature of COVID-19, with tears containing SARS-CoV-2 virus, and a source of potential transmission via aerosols.


Technology driving advances in ophthalmology

Over the past 10 years significant improvements in technology underlying ophthalmic diagnosis and treatment have led to marked improvements in visual outcomes for patients.